MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAU, S. S.
Right arrow Articles by ZANNONI, V. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAU, S. S.
Right arrow Articles by ZANNONI, V. G.

Molecular Pharmacology, Vol 20, 234-235, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Bromobenzene Metabolism in the Rabbit

Specific Forms of Cytochrome P-450 Involved in 2,3- and 3,4-Epoxidation

SERRINE S. LAU 1 and VINCENT G. ZANNONI 1

1 Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan 48109

Previous studies in our laboratory indicated that phenobarbital treatment of rats caused a significant increase in both 2,3- and 3,4-epoxidation of bromobenzene in their hepatic microsomes and that 3-methylcholanthrene or beta-naphthoflavone caused a selective increase in the 2,3-epoxidation pathway. Sodium dodecyl sulfate, polyacrylamide gel electrophoresis of microsomes revealed multiple forms of cytochrome P-450, in keeping with the notion that different species of the heme protein catalyzed the "nontoxic" 2,3-epoxidation and the "toxic" 3,4-epoxidation of this environmental chemical. The present study describes the metabolism of bromobenzene with highly purified cytochrome P-450 and P-448 isolated from rabbit hepatic microsomal preparations. This study involved the enzymatic conversion of bromobenzene to o-bromophenol via 2,3-epoxidation and p-bromophenol via 3,4-epoxidation in a reconstituted mixed-function oxygenase system. Evidence is presented that purified rabbit cytochrome P-450 (LM2) prepared from animals treated with phenobarbital specifically catalyzes the 3,4-epoxidation of bromobenzene to p-bromophenol. Furthermore, evidence is given that purified rabbit cytochrome P-448 (LM4) prepared from animals treated with beta-naphthoflavone specifically catalyzes the 2,3-epoxidation of bromobenzene to o-bromophenol. These data represent an interesting example of two epoxidation pathways involved in the metabolism of a common substrate, one of which leads to cellular damage, i.e., phenobarbital-inducible 3,4-epoxidation; the other, i.e., beta-naphthoflavone-inducible 2,3-epoxidation of bromobenzene, is not particularly detrimental. Each epoxidation pathway preferentially requires a different and specific form of the heme protein.

Note:
ACKNOWLEDGMENTS The authors wish to thank Dr. Minor J. Coon, Mr. L. Gorsky, Mr. L. Cooke, and Ms. S. Pawlowski of the Department of Biochemistry, University of Michigan, for their generous gift of purified rabbit cytochrome P-450 LM2 and LM4, NADPH-cytochrome c reductase, and dilauroylglyceryl-3-phosphorylcholine.

Submitted on January 29, 1981
Accepted on February 17, 1981







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics